Food and Drug Administration labeling and medication guides: A health outcomes critique

Res Social Adm Pharm. 2019 Sep;15(9):1191-1192. doi: 10.1016/j.sapharm.2019.04.007. Epub 2019 Apr 11.

Author

Taylor L Watterson¹

Affiliation

¹ Social & Administrative Sciences Division at the University of Wisconsin - Madison, School of Pharmacy, Madison, United States. Electronic address: twatterson@wisc.edu.

PMID: 31003764
DOI: 10.1016/j.sapharm.2019.04.007

No abstract available

Publication types

Letter

MeSH terms

Analgesics, Opioid / therapeutic use
Drug Labeling / standards*
Humans
Patient Education as Topic
Physicians
Practice Patterns, Physicians'
Prescription Drug Misuse / prevention & control
United States
United States Food and Drug Administration

Substances

Analgesics, Opioid